70% Of Antibiotics Not Working On Patients: Expert

Pune: Noted intensivists from across the country recently gathered in the city to speak at an international symposium on the increasing need for awareness of antimicrobial resistance (AMR).

The 12th annual Best of Brussels symposium was organised by the Indian Society of Critical Care Medicine, Pune chapter. The three-day symposium, ‘Best of Brussels’, started last Friday and a media briefing on the same was held on Saturday.

Dr Shirish Prayag, council member, Sepsis Forum, an NGO, said that it has been observed over the years that about 70% of current antibiotics used to treat various infections are not working on patients. This has led to increased mortality among patients, requiring critical care, by 30%. City-based intensivist Dr Kapil Zirpe said that sepsis would be the leading cause of deaths in the country by 2050 as there is a 7-8% increase year-on-year in outpatients, and 11% among indoor patients who are reporting repeated infections.

Dr Tanu Singhal, consultant paediatrics and infectious diseases, Kokilaben Dhirubhai Ambani Hospital, said “The pipeline of newer drugs is slower and soon we will be in era of pre-antibiotics, where no antibiotics will be left to treat infections.”

Dr Yatin Mehta, chairman, Medanta Institute of Critical Care and Anaesthesiology, said, “Every hospital should have antibiotic stewardship programmes, which should be strictly followed.”

Dr Subhal Dixit, joint organising secretary, Best of Brussels, said, “Data from WHO or Surviving Sepsis guidelines state that 50 million patients were admitted in ICUs across the world due to sepsis. In India, we expect the rates to double by 2050.”

Related Posts

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

The Maharashtra Food and Drug Administration (FDA) seized 3,098.46 tonnes of food stock worth Rs 63.45 crore and suspended 954 food licences during a statewide enforcement drive in the past…

Stents to syringes: Serious harm reports surge, but makers remain unnamed

6-year data disclosed first time by Indian Pharmacopoeia Commission on CIC order The Indian Pharmacopoeia Commission (IPC) has, for the first time, disclosed the number of Serious Adverse Events (SAEs)…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

Stents to syringes: Serious harm reports surge, but makers remain unnamed

Stents to syringes: Serious harm reports surge, but makers remain unnamed

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Medicines that cure Us are making Our Environment Sick

Medicines that cure Us are making Our Environment Sick